Results 301 to 310 of about 349,459 (384)

Identification of diagnostic and therapeutic biomarkers for attention-deficit/hyperactivity disorder. [PDF]

Kaohsiung J Med Sci
Lee SY, Wang LJ, Yen CF.
europepmc   +1 more source

STARDEV Study: Neurodevelopmental Trajectory and Long‐Term Outcomes of Patients with Startle Disease/Hyperekplexia

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Although initial clinical presentation of hyperekplexia/startle disease is well known, data regarding long‐term clinical outcomes is lacking. Objectives We provide a long‐term evaluation from clinical and pharmacological perspectives, focusing on neurodevelopmental trajectory. Methods Twenty‐eight patients from nine French hospitals
Diane Pina, Agathe Roubertie, Marie‐Aude Spitz, Claudia Ravelli, Nadia Bahi‐Buisson, Farha Gheurbi, Marion Buchy, Thomas Loppinet, Nicole Chemaly‐Perin, Marie‐Christine Nougues, Benedicte Heron, Regis Lopez, Mathieu Anheim, Mélanie Fradin, Claude Cances, Justine Avez‐Couturier, Fabienne Dalmon, Gaëtan Lesca, Vincent Des Portes, Laurence Lion‐François   +19 more
wiley   +1 more source

Applications for the management of Attention Deficit Hyperactivity Disorder: a systematic review. [PDF]

Front Public Health
Hosseinnia M, Pirzadeh A, Nazari A, Heidari Z.   +3 more
europepmc   +1 more source

Safety and Effect of 12‐Month Ecopipam Treatment in Pediatric Patients with Tourette Syndrome

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Tourette syndrome (TS) is a chronic neurodevelopmental tic disorder with a considerable quality of life (QOL) burden. Objectives The goal was to determine the long‐term safety, tolerability, and clinical effects of ecopipam, a first‐in‐class dopamine D1 receptor antagonist, for TS.
Donald L. Gilbert, David J.B. Kim, Meredith M. Miller, Sarah D. Atkinson, George B. Karkanias, Frederick E. Munschauer, Stephen P. Wanaski, Timothy M. Cunniff   +7 more
wiley   +1 more source

Tics and Parkinson's Disease: Clinical and Pathophysiological Insights from a Rare Syndromic Association

Movement Disorders Clinical Practice, EarlyView.
Abstract Background The coexistence of tics with Parkinson's disease (PD) is rare, as they often emerge at different ages, follow different trajectories and involve contrasting pathophysiological mechanisms related to dopamine availability and function in the brain. Cases We present 10 individuals with primary tic disorders who later developed PD.
Tarig Abkur, Alexandra Boogers, Talyta Grippe, David A. Isaacs, Irene A. Malaty, Renato P. Munhoz, Kailash P. Bhatia, Lauren A. Hart, Alfonso Fasano, Suneil Kalia, Anthony E. Lang, Christos Ganos   +11 more
wiley   +1 more source

Causal relationship between attention deficit hyperactivity disorder and atherosclerosis: A bidirectional Mendelian randomization study. [PDF]

Medicine (Baltimore)
Hu XY, Chen GL, Yang XF, Zhang N.
europepmc   +1 more source

Management of Anxiety in Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
ABSTRACT Background Anxiety is a common, distressing, hard‐to‐diagnose and hard‐to‐treat symptom in Parkinson's disease. No formal guidelines exist to assist management. Objective We provide a pragmatic guide to detecting and managing anxiety in Parkinson's disease.
Alex J. Berry, Harry Costello, Silvia Jesús, Gary Price, Ashwani Jha   +4 more
wiley   +1 more source

Aniracetam Ameliorates Attention Deficit Hyperactivity Disorder Behavior in Adolescent Mice. [PDF]

eNeuro
Sun XL, Cui J, Bai H, Zhang W, Bai WJ.
europepmc   +1 more source

Identifying novel metabolites in children with attention-deficit hyperactivity disorder through metabolome profiling. [PDF]

Transl Psychiatry
Hung YA, Kuo TC, Tseng YJ, Shang CY, Gau SS.   +4 more
europepmc   +1 more source